Lincoln’s Master of Pharmacy Programme Achieves Full Accreditation from the General Pharmaceutical Council
The University of Lincoln’s School of Pharmacy MPharm programme has been given the seal of approval and has received full accreditation from the General Pharmaceutical Council (GPhC). The School, which was established in 2012, has now confirmed MPharm degrees for its first cohort of students, which also marks the completion of a seven year process […]
The University of Lincoln’s School of Pharmacy MPharm programme has been given the seal of approval and has received full accreditation from the General Pharmaceutical Council (GPhC).
The School, which was established in 2012, has now confirmed MPharm degrees for its first cohort of students, which also marks the completion of a seven year process to receive the full accreditation – a hallmark of quality assurance in the initial university education of pharmacists.
The General Pharmaceutical Council is the regulating body for pharmacists, pharmacy technicians and pharmacies in the UK assuring safe and high standards of care for people using pharmacy services. It sets standards for pharmacy professionals to enter and remain on its register ensuring they continue to meet its standards.
Speaking about the accreditation, which has been achieved with no conditions or recommendations, the GPhC accreditation panel said “the team recognise that there has been a strong collegiate approach in developing this MPharm from the senior leadership, staff and students.’
Dr. Paul Grassby, Head of the School of Pharmacy said: “We are delighted that the School of Pharmacy has now achieved full GPhC accreditation, and we know that the School will continue to develop its exciting and innovative patient facing programme. We are also very proud of our students and what they have achieved – all securing excellent pre-registration positions. ”
The accreditation is the latest success for the School which has already enjoyed international recognition for world-leading research led by Dr Ishwar Singh and a multi-disciplinary team of researchers who are taking significant steps towards developing antibiotics to combat drug-resistant bugs.